FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results.

R. Tamisier (Grenoble, France), T. Damy (Creteil, France), J. Davy (Montpellier, France), J. Verbraecken (Antwerp, Belgium), S. Bailly (Grenoble, France), F. Lavergne (Saint-Priest, France), A. Palot (Marseille, France), F. Goutorbe (Beziers, France), J. Pepin (Grenoble, France), M. D'Ortho (Paris, France)

Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Session: The impact of different treatment modalities on obstructive sleep apnoea
Session type: Oral Presentation
Number: 4737
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Tamisier (Grenoble, France), T. Damy (Creteil, France), J. Davy (Montpellier, France), J. Verbraecken (Antwerp, Belgium), S. Bailly (Grenoble, France), F. Lavergne (Saint-Priest, France), A. Palot (Marseille, France), F. Goutorbe (Beziers, France), J. Pepin (Grenoble, France), M. D'Ortho (Paris, France). FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results.. 4737

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - FACE: Cluster phenotyping predicting outcomes in a prospective multicenter cohort study of chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV).
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019



LATE-BREAKING ABSTRACT: Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Late Breaking Abstract - Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study_Update
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017



Late Breaking Abstract - FACE: Prospective multicenter cohort adressing chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV): patient baseline characteristics
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019

FACE: A prospective multicentre observational cohort study in patients with chronic heart failure (CHF) and central sleep apnoea (CSA) treated with adaptive servoventilation (ASV)
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013


Long-term efficacy of adaptive servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-stokes respiration (CSR). A randomised CPAP-controlled trial
Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation
Year: 2009


Nocturnal oxygen therapy (NOT) versus nasal ventilation with Auto-CS in patients with severe chronic heart failure (CHF) and Cheyne-Stokes respiration (CSR): a long-term study over 2 years
Source: Eur Respir J 2002; 20: Suppl. 38, 9s
Year: 2002

Predictors of 1-year compliance with adaptive servoventilation in patients with heart failure and sleep disordered breathing: preliminary data from the ADVENT-HF trial
Source: Eur Respir J, 53 (2) 1801626; 10.1183/13993003.01626-2018
Year: 2019



Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Efficacy of adaptative servo-ventilation (ASV) versus continuous positive airway pressure (CPAP) in treatment of cheyne-stokes respiration (CSR) in heart failure (HF) patients
Source: Annual Congress 2004 - CPAP therapy for OSA
Year: 2004


Efficacy of auto servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-Stokes respiration (CSR). A randomized CPAP-controlled trial
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010


CPAP versus adaptive servoventilator (ASV) in patient with congestive heart failure and sleep disorder breathing
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012

LATE-BREAKING ABSTRACT: Heart rate variability (HRV) in patients with severe obstructive sleep apnea syndrome (OSA) and its response to a 3-month continuous positive airway pressure (CPAP) therapy
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


Efficacy of and compliance to adaptative servo-ventilation (ASV) for sleep apnea syndrome (SAS) with cheyne-stokes respiration (CSR) in cardiologic versus non-cardiologic patients
Source: Eur Respir J 2004; 24: Suppl. 48, 563s
Year: 2004

Effect of auto servo-ventilation (ASV) and continuous positive airway pressure (CPAP) on B-type natriuretic peptide (NT-proBNP) in patients with co-existing obstructive (OSA) and central sleep apnea (CSA) in heart failure (HF)
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Shuttle walking test (SWT) in the evaluation of patients with congestive heart failure (CHF) and sleep-disordered breathing (SDB)
Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research
Year: 2010


Heart rate variability (HRV) and blood pressure (BP) changes in patients with neuromuscular disease (NMD) following setup of non-invasive ventilation (NIV)
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013


The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


Relationship between severity of chronic heart failure (CHF) and sleep related breathing disorders (SRBD)
Source: Eur Respir J 2006; 28: Suppl. 50, 815s
Year: 2006